Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Selective serotonin reuptake inhibitors are still harmful and ineffective. Responses to the comments by Hieronymus et al

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Light therapy for seasonal affective disorder in visual impairment and blindness - a pilot study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Differentiating Depression and ADHD without Depression in Adults with Processing-Speed Measures

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Association between GLP-1 receptor gene polymorphisms with reward learning, anhedonia and depression diagnosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Low frequency rTMS, inhibits the antidepressive effect of ECT. A pilot study

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Markers of HPA-axis activity and nucleic acid damage from oxidation after electroconvulsive stimulations in rats

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Early specialised palliative care: interventions, symptoms, problems

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Low-dose hydrocortisone in patients with COVID-19 and severe hypoxia: the COVID STEROID randomised, placebo-controlled trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Ongoing and future COVID-19 vaccine clinical trials: challenges and opportunities

    Research output: Contribution to journalReviewResearchpeer-review

View graph of relations

In this response, we address point by point the additional issues raised by Hieronymus et al. in their second round of critique of our systematic review on selective serotonin reuptake inhibitors for major depression. We repulse that we are biased or mistaken in any major ways. We acknowledge that we missed a few small, mostly unpublished trials, and we made a few minor errors in our systematic review. However, these omissions and errors neither have any impact on our overall results nor on our conclusions. The critique by Hieronymus et al. seems to raise questions about their understanding of the systematic review process, and, on several occasions, they wrongly claimed that we made errors. Our analyses should be impartial and free from any biases or prejudices as we do not have any obligation to support the interests of sponsors or other groups.

Original languageEnglish
JournalActa Neuropsychiatrica
Volume31
Issue number5
Pages (from-to)276-284
Number of pages9
ISSN1601-5215
DOIs
Publication statusPublished - Oct 2019

    Research areas

  • antidepressants, clinical trials, depression, serotonin, SSRI

ID: 57627000